Fecci and colleagues show that tumor cells having lost MHC-I, a major mechanism of immune escape, are amenable to killing by CD8+ T cells through an MHC-I-independent, alternative pathway via NKG2D and NKG2DL interaction and granzyme. This evidence concerns the gene CD8A and neoplasm.